C3AR / C3a Receptor Antibody (150-230 aa, Internal)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry (general) |
| Reactivity: | Human |
| Format: | Liquid |
$301.00each
Catalog Number: LS-C382362-50
Catalog Number: LS-C382362
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- C3a Receptor antibody LS-C382362 is an unconjugated rabbit polyclonal antibody to human C3a Receptor (C3AR) (150-230 aa, Internal). Validated for ELISA, IF and IHC. Cited in 1 publication.
- Application
- ELISA, IF, IHC
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- AZ3B | C3AR | C3R1 | C3a receptor | C3a-R | HNFAG09 | Anaphylatoxin c3a receptor | C3a anaphylatoxin receptor | C3AR1
- Recommended Dilution: ELISA
- 1:10000
- Recommended Dilution: IF/ICC
- 1:200 - 1:1000
- Recommended Dilution: IHC
- 1:100 - 1:300
- UniProt Number
- Q16581
- NCBI GenBank
- NM_004054 | NP_004045.1
- SwissProt
- Q16581
Target
- Target
- Human C3AR / C3a Receptor
- Antigen Species
- Human
- Epitope
- C3aR Polyclonal Antibody detects endogenous levels of C3aR protein.
- Gene Name
- C3AR1
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
- Isotype
- IgG
Immunogen
- Immunogen
- Synthesized peptide derived from human C3aR
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
C3a receptor blockade protects podocytes from injury in diabetic nephropathy. Marina Morigi, Luca Perico, Daniela Corna, Monica Locatelli, Paola Cassis, Claudia Elisa Carminati, Silvia Bolognini, Carlamaria Zoja, Giuseppe Remuzzi, Ariela Benigni, Simona Buelli. JCI insight. 2020 Mar;5:e131849. PubMed: 32161193 PMC: PMC7141402